ClinicaliQ Trial Snapshot
- A Study Evaluating the Safety and Tolerability of QRL-201 in ALS — Active Not Recruiting • Phase I • NCT05633459.
- QRL-201 was tested to check if it's safe and tolerable in multiple doses for people with ALS.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
The primary objective of this study is to determine the safety and tolerability of multiple doses of QRL-201 in people living with ALS Conditions: Amyotrophic Lateral Sclerosis Interventions: Multiple ascending doses of QRL-201, Multiple ascending doses of Placebo, QRL-201, Placebo, QRL-201 Lead Sponsor: QurAlis Corporation Planned Enrollment: 69 participants